• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

 

FDA

FDA Core Presentations, Flibanserin, for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs (PDF – 524KB)

 

Boehringer Ingelheim Pharmaceuticals, Inc

Boehringer Ingelheim Core Presentations, Flibanserin, for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs (PDF –2.13MB)

 

Open Public Hearing

OPH Core Presentations, Flibanserin, for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs (PDF – 156KB)